Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Wagner Charles F Jr
Relationship:   EVP & Chief Financial ...
City:   Billerica
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   228,237    

Indirect Shares

  0      
Direct Value   $33,490,857    

Indirect Value

  $0      
Total Shares   228,237      
Total Value   $33,490,857      


Progress Software Corp
 $5,250,399 Bruker Corp
 $5,846,612 Vertex Pharmaceuticals Inc
 $22,393,846 Progress Software Corp
 $5,250,399 Bruker Corp
 $5,846,612 Vertex Pharmaceuticals Inc
 $22,393,846
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Progress Software Corp PRGS EVP Finance & Admin an... 2011-10-14 81,175 0    Premium*  
            Bruker Corp BRKR EVP & Chief Financial ... 2015-03-17 99,925 2012-08-02 0    Premium*  
            Vertex Pharmaceuticals Inc VRTX EVP & Chief Financial ... 2024-06-03 47,137 2019-04-10 0    Premium*  
* Premium Members only  

Records found :    47         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
PRGS Progress Software Corp EVP Finance & Admin and CFO   •       –      –    2011-04-01 4 D $29.53 $75,112 D/D (2,544) 45,456 0 -
PRGS Progress Software Corp EVP Finance & Admin and CFO   •       –      –    2011-10-14 4 A $20.73 $518,250 D/D 25,000 81,175 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2012-08-02 4 A $0.00 $0 D/D 88,028 88,028 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2013-08-02 4 D $19.93 $143,217 D/D (7,186) 80,842 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2013-08-30 4 A $0.00 $0 D/D 25,726 106,568 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2014-08-02 4 D $22.40 $234,662 D/D (10,476) 96,092 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2014-08-08 4 A $0.00 $0 D/D 25,895 121,987 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2014-08-30 4 D $20.26 $62,036 D/D (3,062) 118,925 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2015-03-17 4 S $18.97 $360,493 D/D (19,000) 99,925 0 -
VRTX Vertex Pharmaceuticals In... EVP and CFO   •       –      –    2019-04-10 4 A $0.00 $0 D/D 3,697 3,697 0 -
VRTX Vertex Pharmaceuticals In... EVP and CFO   •       –      –    2020-02-05 4 A $0.00 $0 D/D 14,021 17,816 0 -
VRTX Vertex Pharmaceuticals In... EVP and CFO   •       –      –    2020-02-24 4 D $239.23 $129,663 D/D (542) 17,274 0 -
VRTX Vertex Pharmaceuticals In... EVP and CFO   •       –      –    2020-04-30 4 D $251.78 $137,724 D/D (547) 16,727 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2020-07-10 4 AS $291.19 $205,206 D/D (700) 16,126 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-02-03 4 A $0.00 $0 D/D 21,951 38,138 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-02-10 4 D $214.16 $506,488 D/D (2,365) 35,773 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-02-24 4 D $217.57 $119,011 D/D (547) 35,226 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-04-30 4 D $217.21 $118,814 D/D (547) 34,679 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-01 4 A $0.00 $0 D/D 25,588 60,379 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-02 4 AS $250.07 $736,206 D/D (2,944) 57,435 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-10 4 D $237.74 $578,659 D/D (2,434) 55,001 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-17 4 D $232.51 $799,602 D/D (3,439) 51,562 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-24 4 D $227.86 $498,786 D/D (2,189) 49,373 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-03-17 4 AS $250.13 $793,218 D/D (3,171) 46,202 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-04-01 4 AS $261.42 $683,602 D/D (2,582) 43,620 0 -

  47  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed